Gyre Therapeutics, Inc. GYRE Gyre — Income Tax Expense Benefit

Other segment segments

Similar metrics at other companies

FCCOCorporate — Income Tax Expense Benefit

-$237K-28.1%

AEPG&M — Income Tax Expense (Benefit)

$22M-38.9%

CTB

CTBICorporate — Income Tax Expense Benefit

-$667K+0.7%

BOCGIG — Income Tax Expense Benefit

$0—

COLLSegment — Income Tax Expense (Benefit)

$4.24M+502%

UTLGas — Income Tax Expense Benefit

$11.2M+19.1%

Questions, answered.

What is Gyre Therapeutics, Inc.'s gyre — income tax expense benefit?

Gyre Therapeutics, Inc. (GYRE) reported gyre — income tax expense benefit of $0 in Q1 2026.

What does gyre — income tax expense benefit mean?

This metric represents the total income tax expense or benefit recognized by the specific business segment during the reporting period. It reflects the tax impact of the segment's operations, including current and deferred tax provisions. Monitoring this helps investors understand the tax efficiency and regulatory impact on the segment's bottom line.